Hydration, Sleep, and Movement: The Energy Trifecta Dehydration is frequently mistaken for fatigue
Documentation of Harm: Evidence of the financial and personal impact of the injury, including medical bills, pay stubs, and personal journals detailing the daily effects of the condition
Expect gradual, meaningful fat loss over months, not overnight
Key Takeaways: Read also: Gotrade Daily: AWS Roars Back, Microsoft's Record Day Pfizer keeps expanding its GLP-1 portfolio in China through its second licensing deal in just a few months Ecnoglutide is a once-weekly injection already approved in China, with a weight management application currently under review Competition in the GLP-1 space is heating up fast, with heavyweights like Novo Nordisk and Eli Lilly already leading the pack Ecnoglutide belongs to a class of drugs known as GLP-1 receptor agonists, the same category as Novo Nordisk's Ozempic and Eli Lilly's Mounjaro
GLP-1 while breastfeeding is generally not recommended, and tirzepatide while breastfeeding has similar concerns